Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald M Arnold

Showing results (11-20 of 241) with videos related to

Pageof 25
Sort By:
British Journal of Haematology|February 16, 2010
The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseasesNichola Cooper, Donald M Arnold
Transfusion|May 30, 2008
The use and abuse of surrogate endpoints in clinical research in transfusion medicineDonald M Arnold, Wendy Lim
Seminars in Hematology|October 18, 2011
A rational approach to the diagnosis and management of thrombocytopenia in the hospitalized patientDonald M Arnold, Wendy Lim
Lancet (London, England)|October 1, 2023
Inhibition of neonatal Fc receptor as a treatment for immune thrombocytopeniaSyed Mahamad, Donald M Arnold
The Lancet. Haematology|September 24, 2021
All-trans retinoic acid for treating immune thrombocytopenia: new purpose for an old drug?Nadia Gabarin, Donald M Arnold
Hamostaseologie|June 7, 2019
First-Line Therapy for Immune ThrombocytopeniaSiraj Mithoowani, Donald M Arnold
American Journal of Hematology|February 14, 2015
Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopeniaMichelle Zeller, Donald M Arnold
Seminars in Hematology|January 26, 2008
Current options for the treatment of idiopathic thrombocytopenic purpuraDonald M Arnold, John G Kelton
British Journal of Haematology|November 19, 2010
Pathophysiology and management of chronic immune thrombocytopenia: focusing on what mattersLisa J Toltl, Donald M Arnold
Blood|August 8, 2008
"Spare-spleen-uximab" for chronic ITPTheodore E Warkentin, Donald M Arnold
Pageof 25

Showing results (11-20 of 241) with videos related to

Sort By:
Pageof 25
British Journal of Haematology|February 16, 2010
The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseasesNichola Cooper, Donald M Arnold
Transfusion|May 30, 2008
The use and abuse of surrogate endpoints in clinical research in transfusion medicineDonald M Arnold, Wendy Lim
Seminars in Hematology|October 18, 2011
A rational approach to the diagnosis and management of thrombocytopenia in the hospitalized patientDonald M Arnold, Wendy Lim
Lancet (London, England)|October 1, 2023
Inhibition of neonatal Fc receptor as a treatment for immune thrombocytopeniaSyed Mahamad, Donald M Arnold
The Lancet. Haematology|September 24, 2021
All-trans retinoic acid for treating immune thrombocytopenia: new purpose for an old drug?Nadia Gabarin, Donald M Arnold
Hamostaseologie|June 7, 2019
First-Line Therapy for Immune ThrombocytopeniaSiraj Mithoowani, Donald M Arnold
American Journal of Hematology|February 14, 2015
Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopeniaMichelle Zeller, Donald M Arnold
Seminars in Hematology|January 26, 2008
Current options for the treatment of idiopathic thrombocytopenic purpuraDonald M Arnold, John G Kelton
British Journal of Haematology|November 19, 2010
Pathophysiology and management of chronic immune thrombocytopenia: focusing on what mattersLisa J Toltl, Donald M Arnold
Blood|August 8, 2008
"Spare-spleen-uximab" for chronic ITPTheodore E Warkentin, Donald M Arnold
Pageof 25